The impact of PET on the management of lung cancer: The referring physician's perspective

Journal of Nuclear Medicine

Volumn 43, Issue 6, 2002, Pages 752-756

  Seltzer, Marc A ^a   Yap, Cecelia S ^a   Silverman, Daniel H ^a   Meta, Joubin ^a   Schiepers, Christiaan ^a   Phelps, Michael E ^a   Gambhir, Sanjiv S ^a   Rao, Jyotsna ^a   Valk, Peter E ^a   Czernin, Johannes ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

18F FDG PET; Lung cancer staging; Questionaire

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; ENZYME PHOSPHORYLATION; FEMALE; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT OUTCOME;

ATTITUDE OF HEALTH PERSONNEL; DATA COLLECTION; DISEASE MANAGEMENT; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; NEOPLASM STAGING; QUESTIONNAIRES; REFERRAL AND CONSULTATION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036086158     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. PET in oncology: Will it replace the other modalities?
2. 18F]-FDG in oncology: A clinical update
3. The metabolism of cancer cells
4. Enzymology of cancer cells. Part 1
5. Enzymology of cancer cells. Part 2
6. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes
7. Comparative chemistry of hepatomas 5123
8. PET in lung cancer
9. Cost analysis of FDG PET for managing patients with ovarian cancer
10. A tabulated summary of the FDG PET literature
11. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: Implications for radical radiation therapy
12. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with non-small cell lung carcinoma: Powerful correlation with survival and high impact on treatment
13. Clinical impact of F-18 fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study
14. 18F-FDG PET on managing patients with colorectal cancer: The referring physician's perspective
15. 18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma
16. 18F-FDG PET on staging and managing patients with breast cancer: The referring physician's perspective
17. Internet Question and Answer (iQ & A): A web-based survey technology
18. Whole-body positron emission tomography. Part I. Methods and performance characteristics
19. Performance evaluation of the whole-body PET scanner ECAT EXACT HR+ following the IEC standard
20. Accelerated EM reconstruction in total-body PET: Potential for improving tumour detectability
21. A theoretical study of the contrast recovery and variance of MAP reconstructions from PET data
22. Revisions in the international system for staging lung cancer
23. Cost-effectiveness of PET imaging in clinical oncology
24. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma
25. The incremental value of diagnostic tests
26. Professionals as responders: Variations in and effects of response rates to questionnaires 1961-77
27. Maximising response rates in a survey of general practitioners: Lessons from a Victorian survey on sexually transmissible diseases
28. Physician participation in research surveys: A randomized study of inducements to return mailed research questionnaires
29. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s-meta-analytic comparison of PET and CT
30. The impact of whole body PET FDG-PET on staging of lung cancer
31. PET begins to prove itself in cancer care
32. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer
33. Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer
34. Preoperative staging of non-small-cell lung cancer with positron-emission tomography